Skip to main content
Arctic Bioscience logo

Arctic Bioscience — Investor Relations & Filings

Ticker · ABS ISIN · NO0010859580 LEI · 549300Z2HW6I989Q2C78 OL Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2025-05-08 Capital/Financing Update
Country NO Norway
Listing OL ABS

About Arctic Bioscience

https://arctic-bioscience.com/

Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical and nutraceutical products derived from marine membrane lipids. The company utilizes proprietary technology to extract bioactive compounds from herring roe, sourced from sustainable, MSC-certified fisheries. Its nutraceutical product line, marketed under the brand name Romega, consists of high-DHA Omega-3 phospholipid extracts. The pharmaceutical division is focused on developing a novel drug candidate for the treatment of mild-to-moderate psoriasis, aligning with its mission to create therapies for autoimmune disorders. The company's work is supported by extensive research and development to validate the efficacy of its marine-based ingredients.

Recent filings

Filing Released Lang Actions
Arctic Bioscience - Styrets godkjennelse av kapitaløkning relatert til gjeldskonvertering
Capital/Financing Update Classification · 98% confidence The document text is a short announcement (2091 characters) titled 'Arctic Bioscience - Styrets godkjennelse av kapitaløkning relatert til gjeldskonvertering' (Board's approval of capital increase related to debt conversion). It details the board's decision to increase share capital by issuing 170,000 new shares to settle debt, specifying the nominal value, subscription price, and resulting total share count. This clearly relates to a change in the company's capital structure due to financing/debt settlement. This aligns directly with the definition for 'Capital/Financing Update' (CAP). Although it mentions an attachment ('Referat fra styremøtet og redegjørelse i anledning kapitalforhøyelse er vedlagt'), the core content is the financing decision itself, making CAP more specific than RPA or RNS, especially given the explicit financial details provided.
2025-05-08 Norwegian
Arctic Bioscience - Board approval of share capital increase related to conversion of debt
Share Issue/Capital Change Classification · 98% confidence The document explicitly details a resolution by the Board of Directors to increase the share capital by issuing new shares following the conversion of debt. Key phrases include 'Board approval of share capital increase related to conversion of debt,' 'resolved to increase the share capital... by issuance of 170 000 new shares,' and the resulting change in the total number of shares. This directly corresponds to the definition of 'Share Issue/Capital Change' (SHA). Although it mentions attachments, the core content is the announcement of the capital change itself, making SHA more specific than RPA or RNS.
2025-05-08 English
Arctic Bioscience - Annual report 2024
Annual Report Classification · 100% confidence The document is explicitly titled 'ANNUAL REPORT 2024' and contains comprehensive sections including a letter from the CEO, key financial figures (Income Statement, Balance Sheet, Cash Flow), management reports, and an independent auditor's report. It covers the full fiscal year 2024 and provides detailed financial and operational performance data, fitting the definition of an Annual Report (10-K). FY 2024
2025-05-07 English
Arctic Bioscience - Årsrapport 2024
Annual Report Classification · 100% confidence The document is explicitly titled 'ANNUAL REPORT 2024' and contains comprehensive sections including a letter from the CEO, key financial figures (Income Statement, Balance Sheet, Cash Flow), management reports, and an independent auditor's report. It covers the full fiscal year 2024 and provides detailed financial and operational performance data, fitting the definition of an Annual Report (10-K). FY 2024
2025-05-07 English
Arctic Bioscience - Annual report 2024
Report Publication Announcement Classification · 99% confidence The document explicitly states it is the "Arctic Bioscience - Annual report 2024" and mentions it includes the "Board of Directors report and financial statements." This strongly suggests it is the official yearly report. However, the document is short (2291 chars) and ends with the statement: "The report is attached to this stock notice and is available on the company's website." According to Rule #2 (The 'MENU VS MEAL' Rule), when a short document announces the publication of a full report and states it is attached or available elsewhere, it should be classified as a Report Publication Announcement (RPA), not the full report itself (10-K). Although the content describes the contents of an Annual Report, the format is that of an announcement of its release.
2025-05-07 English
Arctic Bioscience - Årsrapport 2024
Report Publication Announcement Classification · 99% confidence The document is titled "Arctic Bioscience - Årsrapport 2024" (Annual Report 2024) and explicitly states that the company has published its annual report for 2024, including the board's annual review and accounts ('årsberetning og regnskap'). It details financial adjustments for Q4 2024 and the full year 2024. Although it mentions the report is attached/available, the content provided is an announcement *about* the publication of the full annual report, which typically falls under the scope of an Earnings Release (ER) or a Report Publication Announcement (RPA) if it were just a brief notice. However, since the document explicitly names and discusses the contents of the 'Årsrapport' (Annual Report), and the text length is relatively short (2267 chars), it strongly suggests this is the announcement of the full annual report release. Given the options, the most appropriate classification for an announcement detailing the release of the full annual report, especially when the text itself is brief and points to the attached/published document, is Report Publication Announcement (RPA). If the text were the full, detailed 10-K equivalent, it would be 10-K. Since it's the announcement of the 'Årsrapport', RPA is the best fit based on the 'MENU VS MEAL' rule, as it is announcing the publication of the full report.
2025-05-07 Norwegian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.